Original paper
Anticancer activities of a benzimidazole compound through sirtuin inhibition in colorectal cancer
Abstract
This study aims to investigate the mode of action of a novel sirtuin inhibitor (BZD9L1) and its associated molecular pathways in colorectal cancer (CRC) cells.BZD9L1 was tested against metastatic CRC cell lines to evaluate cytotoxicity, cell cycle and apoptosis, senescence, apoptosis related genes and protein expressions, as well as effect against major cancer signaling pathways.BZD9L1 reduced the viability, cell migration and colony forming...
Paper Details
Title
Anticancer activities of a benzimidazole compound through sirtuin inhibition in colorectal cancer
Published Date
Sep 1, 2018
Journal
Volume
10
Issue
17
Pages
2039 - 2057
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History